Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia

计划入组 15 人 · 首次发布于 2014 年 3 月 3 日

Pyrexia Management Using an IL-6 Antibody in BRAF+ Melanoma Patients Treated with Dabrafenib/ Trametinib +/- Immunotherapy

计划入组 20 人 · 首次发布于 2020 年 12 月 3 日

ARTEMIS - The ARTEMIS Cohort

计划入组 50 人 · 首次发布于 2026 年 2 月 19 日

ArtemiC

Artemin

Anemia (Scholar Rock)

Altena, Renske

Sweden

Altamira Therapeutics AG

Switzerland

UNIVERSIDAD DE ALMERIA

Spain

Lobe Sciences Secures European Patent Protection for DHA-Based Sickle Cell Disease Treatment

Lobe Sciences Secures $6M Private Placement for Novel Conjugated Psilocin Development in Chronic Cluster Headache

OSE Immunotherapeutics Launches Phase 3 Trial of Tedopi® for Second-Line NSCLC